Published in
Elsevier, The Lancet Respiratory Medicine, 6(9), p. 585-592, 2021
DOI: 10.1016/s2213-2600(20)30362-3
Links
Tools
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial
Journal article published in 2021 by
Cornedine J. de Gooijer,
Vincent van der Noort,
Jos A. Stigt,
Paul Baas,
Bonne Biesma,
Robin Cornelissen,
Nico van Walree,
Robbert C. van Heemst,
Magdolen Youssef-El Soud,
Harry J. M. Groen,
Agnes J. Staal-Van den Brekel,
Wieneke A. Buikhuisen,
Gerben P. Bootsma,
Floris Dammeijer,
Harm van Tinteren 
and other authors.
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 